IMARC Group’s latest research report, titled “Smart Inhalers Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2027,” offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.
The global smart inhalers market reached a value of US$ 162.75 Million in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 630.25 Million by 2027, exhibiting a CAGR of 27.30% during 2022-2027. Smart inhalers refer to the appliances that are utilized for delivering a wide range of drugs by inhalation. They function by monitoring the dose per intake and medication inhalation technique, sending reminders, and detecting patients’ environments via the attached clip-on sensors. This data is then shared with the patient and healthcare professionals using Bluetooth via an online platform that helps track their inhaler usage. Mainly utilized for treating and preventing respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), they help maintain medical records digitally in an efficient manner.
Get Free Sample Copy of Report at – https://www.imarcgroup.com/smart-inhalers-market/requestsample
Important Attribute and highlights of the Report:
- Detailed analysis of the global market share
- Market Segmentation by product, indication and distribution channel.
- Historical, current, and projected size of the market in terms of volume and value
- Latest industry trends and developments
- Competitive Landscape for Smart Inhalers Market
- Strategies of major players and product offerings
The market is primarily driven by the increasing prevalence of chronic respiratory diseases. Besides this, the rising susceptibility to indoor air pollutants and particulates due to the extensive usage of kerosene lamps and portable stoves is acting as a significant growth-inducing factor for the market. Furthermore, the expanding healthcare expenditure, the considerable rise in air pollution levels, and extensive research and development (R&D) activities conducted by key players are also creating a positive outlook for the market.
Key Players Included in Global Smart Inhalers Market Research Report:
- 3M Company
- Adherium Limited
- AptarGroup Inc.
- AstraZeneca plc
- Boehringer Ingelheim
- Cognita Labs
- GlaxoSmithKline plc
- Novartis AG
- OPKO Health Inc.
- Propeller Health (ResMed)
- Sensirion AG
- Teva Pharmaceutical Industries Ltd.
- Vectura Group Limited (Philip Morris International Inc.)
COVID-19 Impact Overview:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Key Market Segmentation:
Breakup by Product:
- Dry Powdered Inhaler
- Metered Dose Inhaler
Breakup by Indication:
- Chronic Obstructive Pulmonary Disease (COPD)
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Stores
Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
TOC for the Smart Inhalers Market Research Report:
- Scope and Methodology
- Executive Summary
- Global Smart Inhalers Market
- SWOT Analysis
- Value Chain Analysis
- Price Analysis
- Competitive Landscape
Who we are:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800